Tiagabine hydrochloride
98%
- Product Code: 54632
CAS:
145821-59-6
| Molecular Weight: | 412.01 g./mol | Molecular Formula: | C₂₀H₂₆ClNO₂S₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD07369025 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, store under inert gas |
Product Description:
Tiagabine hydrochloride is primarily used as an anticonvulsant medication for the treatment of epilepsy. It is specifically prescribed to manage partial seizures in adults and children over the age of 12. The drug works by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits excessive electrical activity in the brain, thereby reducing the frequency and severity of seizures. It is often used as an adjunctive therapy, meaning it is added to other antiepileptic drugs when they alone are not sufficient to control seizures. Additionally, tiagabine hydrochloride has been explored for its potential in treating other neurological conditions, such as anxiety disorders and neuropathic pain, although these uses are not yet widely established. It is administered orally in tablet form, and dosage is carefully adjusted based on the patient's response and tolerance.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Light yellow powder to crystal |
| PURITY | 97.5-100 |
| Specific rotation a20D C1 H2O | -12.0--9.0 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | ฿4,490.00 |
+
-
|
Tiagabine hydrochloride
Tiagabine hydrochloride is primarily used as an anticonvulsant medication for the treatment of epilepsy. It is specifically prescribed to manage partial seizures in adults and children over the age of 12. The drug works by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits excessive electrical activity in the brain, thereby reducing the frequency and severity of seizures. It is often used as an adjunctive therapy, meaning it is added to other antiepileptic drugs when they alone are not sufficient to control seizures. Additionally, tiagabine hydrochloride has been explored for its potential in treating other neurological conditions, such as anxiety disorders and neuropathic pain, although these uses are not yet widely established. It is administered orally in tablet form, and dosage is carefully adjusted based on the patient's response and tolerance.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :